Product Information
PRASUGREL 5 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.2592 per EA under NDC 00378518593. Its NADAC has been published 463 times since Nov 22, 2017.
FDA first approved this application on Jul 12, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378518593
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PRASUGREL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205927FDA Approved
7/12/2017
TE Code
AB
On Market Since
8/16/2017
Pharmacological Classes
Price Statistics
The NADAC for PRASUGREL 5 MG TABLET has been published 463 times since Nov 22, 2017, and over the history we have for it it has declined 97.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2592 per EA |
|---|---|
| All-time high | $11.4441 (Jan 10, 2018) |
| All-time low | $0.2539 (May 22, 2024) |
| 52-week high | $0.3519 |
| 52-week low | $0.2592 |
| Median price | $0.4332 |
| Average price | $0.6608 |
| Largest weekly change | -84.9% (Feb 21, 2018) |
| Weeks tracked | 463 |
| Tracking since | Nov 22, 2017 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Prasugrel market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
P2Y12 Platelet Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PRASUGREL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PRASUGREL 5 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.2592 per EA (NDC 00378518593), effective Sep 30, 2026.
How has the price of PRASUGREL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for PRASUGREL 5 MG TABLET has declined 97.7%. It has been tracked across 463 weekly CMS publications since Nov 22, 2017.
What are the highest and lowest recorded NADAC prices for PRASUGREL 5 MG TABLET?
Since Nov 22, 2017, the NADAC for PRASUGREL 5 MG TABLET has ranged from a low of $0.2539 (May 22, 2024) to a high of $11.4441 (Jan 10, 2018), with a median of $0.4332 per EA.
Are there cheaper alternatives to PRASUGREL 5 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PRASUGREL 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PRASUGREL 5 MG TABLET?
PRASUGREL 5 MG TABLET (NDC 00378518593) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.